Australian firm to tap in on China’s ‘booming’ infant formula market
date:Jul 06, 2012
class with increased purchasing power and Chinas one child policy that lets parents put more into their only childs welfare.

Current business with China solid

GMPs existing business in supplements sees around 15-20% of revenues coming from China, Patel detailed.

However, with infant formula, it is anticipated China will dominate revenues to the tune of at least 80%.

The company already has an office in Beijing and a staff of 80 working directly with clients there, he revealed.

On the questi
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/03 19:09